Context
- India BioEconomy Report 2026 released during BIRAC’s 14th Foundation Day, prepared by ABLE.
- Bioeconomy is emerging as a key pillar of India’s sustainable growth strategy.
What is Bioeconomy?
- It refers to an economy based on biological resources such as plants, animals, and microorganisms.
- It uses biotechnology-driven processes to produce medicines, biofuels, food, and biomaterials.
- The bio-economy aims to promote sustainability by reducing dependence on fossil fuels.
Key Data & Trends
- Bioeconomy size reached $195.3 billion (2025) with 18% growth rate. It contributes around 4.8–5% of India’s GDP.
- Over 11,855 biotech startups, with 1,780 added in 2025.
- More than 150 life sciences Global Capability Centers (GCCs) employing 3 lakh professionals.
- Sectoral imbalance: BioIndustrial ($90.2 billion) dominates over BioAgri ($14.6 billion).
Challenges
- Regulatory and IP constraints
- Complex biosimilar litigation limits growth opportunities.
- Need for specialised workforce to match global regulatory standards.
- High capital intensity
- Biotech requires long-term funding for trials and commercialisation.
- Startups face difficulty in scaling beyond initial stages.
- Global competition and brain drain
- Multinational R&D dispersal leads to loss of skilled talent.
- Limited high-end research restricts global competitiveness.
- Sectoral imbalance
- Weak adoption of biotechnology in agriculture (BioAgri lagging).
- Innovation-to-market gap
- Poor industry-academia linkage hampers commercialisation of research.
Way Forward
- Strengthen collaborative ecosystem: Enhance coordination among government, academia, and industry and expand role of BIRAC in incubation and innovation scaling.
- Leverage global opportunities: Use patent expiries to lead in biosimilars and pharmaceuticals.
- Enhance Global Capability Centers (GCCs) role: Develop GCCs as hubs for advanced R&D and digital health innovation.
- Support startup ecosystem: Provide targeted incentives, funding, and scale-up support.
- Promote balanced growth: Boost biotechnology adoption in agriculture sector.
- Align long-term policies: Integrate Bio-E3 Policy and National Bio-Pharma Mission with Vision 2047 goals.
Conclusion
- Bioeconomy is becoming a strategic driver of economic growth and sustainability. Thus, addressing structural gaps in funding, regulation, and innovation is essential. With focused reforms, India can achieve its goal of a $1 trillion bioeconomy by 2047.